InChI: | InChI=1/C18H20N2O.C4H6O6/c19-17(21)18(16-11-12-20-13-16,14-7-3-1-4-8-14)15-9-5-2-6-10-15;5-1(3(7)8)2(6)4(9)10/h1-10,16,20H,11-13H2,(H2,19,21);1-2,5-6H,(H,7,8)(H,9,10)/t16-;1-,2-/m11/s1 |
Specification: |
The 3-(S)-(+)-(1-Carbamoyl-1,1-diphenylmethyl)pyrroloidine-L-(+)-tartarate with the cas number 134002-26-9. It is also called (1)(2R,3R)-2,3-Dihydroxysuccinic acid - 2,2-diphenyl-2-[(3S)-pyrrolidin-3-yl]acetamide (1:1); (2)2,2-diphenyl-2-[(3S)-pyrrolidin-3-yl]acetamide 2,3-dihydroxybutanedioate (1:1); (3)butanedioic acid, 2,3-dihydroxy-, (2R,3R)-, compd. with (3S)-alpha,alpha-diphenyl-3-pyrrolidineacetamide (1:1). It blongs to the following product categories such as :(1)Pharmaceutical material and intermeidates; (2)Intermediatesofdarifenacin; (3)API intermediates; (4)Benzenes .
This chemical seems like white powder, and it is usually used for intermediates of Darifenacin. 3-(S)-(+)-(1-Carbamoyl-1,1-diphenylmethyl)pyrroloidine-L-(+)-tartarate is already available in the market. Let me introduce some suppliers in China. For instance, Dalian Wista Pharmaceutical Co., Ltd. and Chengdu Sino-Strong Pharmaceutical Co., Ltd.
You can still convert the following datas into molecular structure :
1.SMILES: c1ccc(cc1)C(c2ccccc2)(C3CCNC3)C(=O)N.C(C(C(=O)O)O)(C(=O)O)O
2. InChI: InChI=1/C18H20N2O.C4H6O6/c19-17(21)18(16-11-12-20-13-16,14-7-3-1-4-8-14)15-9-5-2-6-10-15;5-1(3(7)8)2(6)4(9)10/h1-10,16,20H,11-13H2,(H2,19,21);1-2,5-6H,(H,7,8)(H,9,10)/t16-;1-,2-/m11/s1
|